$ARIA Company News Ariad falls after wild ride upward,

New Post Public Reply Private Reply Replies (0) Message Board

Feb 6, 2014 at 10:17 AM

$ARIA Company News

Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy

'Mad Money' Lightning Round: We Don't Want Molycorp 6:00 a.m. Today - TheStreet.com
Cramer's Lightning Round - If I Want Security, I Want Palo Alto (2/5/14) 5:57 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: A Matter of Distrust 7:51 p.m. Feb. 5, 2014 - TheStreet.com
Ariad Pharma's Executive Stock Giveaway Kills Takeover Hopes 8:00 a.m. Feb. 5, 2014 - TheStreet.com
Investors are betting against Ariad Pharmaceuticals (ARIA), Should You? - Tale of the Tape 6:59 a.m. Feb. 4, 2014 - Zacks.com
Ohr Pharmaceutical (OHRP) Catches Eye: Stock Up 5.0% - Tale of the Tape 9:25 a.m. Feb. 3, 2014 - Zacks.com
Pre-Market Laggard: Ariad Pharmaceuticals (ARIA) 8:16 a.m. Feb. 3, 2014 - TheStreet.com
Biotech Stock Mailbag: Cell Therapeutics and the Ariad Hostile React-o-Meter Meltdown 6:00 a.m. Jan. 31, 2014 - TheStreet.com
ARIAD/Specialised Therapeutics Join Forces for Iclusig - Analyst Blog 5:40 p.m. Jan. 29, 2014 - Zacks.com
Why Heron (HRTX) Has A Bright Short-Term Future? - Tale of the Tape 8:37 a.m. Jan. 29, 2014 - Zacks.com
Tug Of War In Ariad Pharmaceuticals 1:36 p.m. Jan. 28, 2014 - benzinga.com
Ariad Pharmaceuticals (ARIA) Showing Signs Of A Dead Cat Bounce Today 9:47 a.m. Jan. 28, 2014 - TheStreet.com
Benzinga's M&A Chatter for Monday January 27, 2014 4:21 p.m. Jan. 27, 2014 - benzinga.com
Ariad Pharma Short Seller Explains Why Takeover Rumor is Bunk 11:34 a.m. Jan. 27, 2014 - TheStreet.com
Ariad Pharmaceuticals (ARIA) Highlighted As Today's Perilous Reversal Stock 10:38 a.m. Jan. 27, 2014 - TheStreet.com
Top Trending Tickers On StockTwits For January 27 8:20 a.m. Jan. 27, 2014 - benzinga.com
Analyst Reason No. 345 to Upgrade Biotech Stocks: Takeover Rumors in the Foreign Press! 3:40 p.m. Jan. 24, 2014 - TheStreet.com
Ariad Shares Continue to Surge Amidst Buyout Rumors 3:06 p.m. Jan. 24, 2014 - benzinga.com
Ariad Pharnaceuticals Continues To Rally 2:32 p.m. Jan. 24, 2014 - benzinga.com
Mid-Afternoon Market Update: Markets Get Hammered on China Fears as Microsoft Provides on of the Few Havens of Strength 2:32 p.m. Jan. 24, 2014 - benzinga.com

TrendingWallStreet.com Announces Coverage on DDD, ARIA, ENIP, and LATF 12:24 a.m. Today - ACCESSWIRE
ARIAD to Present at the Leerink Swann Global Healthcare Conference 7:35 a.m. Feb. 5, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia 7:35 a.m. Jan. 28, 2014 - BusinessWire - BZX
ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S. 7:35 a.m. Jan. 17, 2014 - BusinessWire - BZX
Divestiture, Service Deployment, Executive Promotion, Updated Outlook, and Designation Granted-Research Report on Endo, ARIAD, Align Technology, PAREXEL, and The Medicines Company 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease 7:35 a.m. Jan. 14, 2014 - BusinessWire - BZX
Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib) 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology 11:10 a.m. Jan. 8, 2014 - ACCESSWIRE
Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Jan. 7, 2014 - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HSBC Boosts Tender Offer: Capital Management Maneuver

HSBC Raises Stake in Its Own Game See folks, when HSBC announces it's bumping up the ceiling on buying back its own securities, you know there's a game afoot in the capital management arena. They raised the offering to snag up these $3 billion 6% perpetuals from $1 billion up to a hefty $1.5 billion. It's like they’re saying, 'Hey, let’s tighten the belt and make sure...

SAS: A Leader in AML Transaction Monitoring Tech

The Evolving Landscape of AML Solutions Banks are drowning in a sea of alerts these days, making it tough to sift through and identify real threats. In this wild scenario, SAS has snagged the spotlight, with Chartis Research tipping its hat to them again. Their Anti-Money Laundering (AML) technology is planted right at the cutting edge of this rapidly changing landscape....

Aries Ignites a Social Renaissance in La Jolla

The Dawn of Aries: A Beacon for Social Change Coming out of nowhere, Aries is set to make waves in La Jolla, and no, I'm not talking about another swell hitting the shores. Instead, we're witnessing a new chapter for the rooftop of Hotel La Jolla, where an investment of over a cool million bucks aims to deliver a slice of European flare right here on the Pacific. A...

iQIYI's AI Resurrects 90-Year-Old Lost Film

A Nod to the Past with Tech of Tomorrow Diving into the nitty-gritty of iQIYI's latest cinematic triumph, there's a world where film meets futuristic AI, turning a motley crew of photos and clippings into a full-fledged movie. It's sorcery, if you ask me. "Visiting Shanghai after Sixty Years", vanished for nearly 90 years, has been crafted into existence again by...

AutoFull Drops C3 Pro—Gaming Chairs With Flair

AutoFull Gambles on Flair and Comfort AutoFull is shaking things up with the C3 Pro Series, blending striking aesthetics and tech-focused comfort features aimed right at gamers' sweet spots. Launching ahead of the Black Friday buzz, these new models promise to add some serious pizzazz to your gaming setup, whether it's the Advanced model's extra features or the more basic...

Major Donations Boost Mesothelioma Research Funding

Significant Boosts in Mesothelioma Support November's chill didn't slow down major support for mesothelioma initiatives. On October 22, 2026, during the grand setting of the Foundation's 2026 International Symposium on Malignant Mesothelioma in The Woodlands, Texas, MesoCare.org and Danziger & De Llano, LLP stepped up big time. Their philanthropic moves weren't just about...

Kuaishou Prepares for Q3 Financial Reveals—November 19

We're watching the countdown to November 19, 2026, when Kuaishou Technology plans to spill the beans on its third-quarter earnings. Now, the clock's ticking not just in Beijing but across the financial landscape, as investors everywhere hold their breaths, hoping for some juicy financial insights from this colossal social platform. It's a heavyweight showdown any stock...

AiNET Prevails in Breach of Contract Jury Verdict

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Custom Antibody Market Eyes $1.13B by 2031 Growth

Examining the Custom Antibody Market's Growth Projections The custom antibody market's been reeling in some serious attention lately. With the muscle to hit $1.13 billion by the end of 2031, this market's not slouching around. We're talking about a 9.5% compound annual growth rate here, folks. Now that's a figure that gives you something to chew over your coffee. What...

Alley Cat Allies Sues Lincolnton Over Cat Shooting

Legal Battle Over a Cat's Tragic End Picture the scene: a peaceful neighborhood in Lincolnton, Georgia, where the serenity was ripped apart by the shocking shooting of Piper the cat. This isn't some playground scuffle, my friends. Alley Cat Allies has taken this tragedy to the courts, filing a lawsuit against the city and its mayor. What's at stake here isn't just legal...